Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.968340
Abstract: Risk stratification in acute myeloid leukemia (AML) has been extensively improved thanks to the incorporation of recurrent cytogenomic alterations into risk stratification guidelines. However, mortality rates among fit patients assigned to low or intermediate risk… read more here.
Keywords: signature; expression signature; stellae 123; gene expression ... See more keywords